Desert Messenger

Amateur radio provides the most reliable communications. We encourage church members and all citizens in the commu- nity to take advantage of training and free testing offered by the Quartzsite Amateur Radio Association (QARA), headed by long time Quartszite resident Dick Thompson, N6WIZ, phone number 360-490-5700. " "We also encourage local ham radio operators to volunteer to provide ra- dio links for block leaders for both the LDS and Neighborhood Watch pro- grams. We are in need of radio operators in Rainbow Acres and other areas where ham radio operators may live. When the phones go down and the washes are running full, radio may be the only means of communications." April 5, 2017 www.DesertMessenger.com 17 LDS FROM PAGE 16 Epi Pen recall The U.S. Food and Drug Admin- istration is alerting consumers to Meridian Medical Technologies' voluntary recalldisclaimer icon of 13 lots of Mylan's EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe al- lergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices' failure to activate. The recalled product was manufactured by Meridian Medi- cal Technologies and distributed by Mylan Specialty. While the number of reported fail- ures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes un- treated. Consumers should keep and use their current EpiPens if needed until they get a replace- ment. Consumers should contact Mylan at 800-796-9526 or cus- tomer.service@mylan.com with any questions. As stated on the product label, con- sumers should always seek emer- gency medical help right away after using their EpiPens, particularly if the device did not activate. At this time, the 13 lots identified – distributed between Dec. 17, 2015, and July 1, 2016 – are the only EpiPen lots impacted by the U.S. re- call. Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date. The FDA asks health care profes- sionals and consumers to report any adverse reactions or device mal- functions to the FDA's MedWatch program, by: Completing and submitting the re- port online at www.fda.gov/med- watch/report.htm, or Downloading and completing the form, then submitting it via fax at 800-FDA-0178. Visit www.fda.gov for details and the full list of lot numbers. T��� ����� ������� �� D����� M�������� • Birth • Obituary • Anniversary Place it FREE in the: Desert Messenger! 928-916-4235 Got something to share?

• Cover